tiprankstipranks
Valeo Pharma (DE:VP2)
FRANKFURT:VP2
Holding DE:VP2?
Track your performance easily

Valeo Pharma (VP2) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
4Neutral
13Bearish
Technical Analysis Consensus
Buy
5Bullish
4Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Valeo Pharma’s (VP2) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Valeo Pharma is a Buy.
Valeo Pharma’s (VP2) 20-Day exponential moving average is 0.05, while Valeo Pharma’s (VP2) share price is <€0.1, making it a Sell.
Valeo Pharma’s (VP2) 50-Day exponential moving average is 0.05, while Valeo Pharma’s (VP2) share price is <€0.1, making it a Sell.

Valeo Pharma (VP2) Pivot Points

Dec 22, 2024, 11:09 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.04
0.04
0.04
0.04
0.04
0.04
0.04
Fibonacci
0.04
0.04
0.04
0.04
0.04
0.04
0.04
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Valeo Pharma (VP2) Moving Averages

Dec 22, 2024, 11:09 PM
Period
Simple
Exponential
MA5
0.05Sell
0.05Sell
MA10
0.05Sell
0.05Sell
MA20
0.05Sell
0.05Sell
MA50
0.05Sell
0.05Sell
MA100
0.07Sell
0.07Sell
MA200
0.09Sell
0.10Sell
Valeo Pharma’s (VP2) 10-Day exponential moving average is 0.05, while Valeo Pharma’s (VP2) share price is <€0.1, making it a Sell.
Valeo Pharma’s (VP2) 100-Day exponential moving average is 0.07, while Valeo Pharma’s (VP2) share price is <€0.1, making it a Sell.
Valeo Pharma’s (VP2) stock price is <€0.1 and Valeo Pharma’s (VP2) 50-day simple moving average is 0.05, creating a Sell signal.
Valeo Pharma’s (VP2) stock price is <€0.1 and Valeo Pharma’s (VP2) 100-day simple moving average is 0.07, creating a Sell signal.
Valeo Pharma’s (VP2) stock price is <€0.1 and Valeo Pharma’s (VP2) 200-day simple moving average is 0.09, creating a Sell signal.

Valeo Pharma (VP2) Technical Indicators

Dec 22, 2024, 11:09 PM
Name
Value
Implied Action
RSI (14)
47.16
Neutral
STOCH (9,6)
12.50
Buy
STOCHRSI (14)
11.27
Buy
MACD (12,26)
>-0.01
Buy
ADX (14)
25.98
Neutral
Williams %R
-87.50
Buy
CCI (14)
-76.92
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
65.67
Neutral
ROC
5.00
Buy
Valeo Pharma’s (VP2) Relative Strength Index (RSI) is 47.16, creating a Neutral signal.
Valeo Pharma’s (VP2) Trend Strength Indicator (ADX) is 25.98, creating a Neutral signal.
Valeo Pharma’s (VP2) Commodity Channel Index (CCI) is -76.92, creating a Neutral signal.
Valeo Pharma’s (VP2) Price Rate of Change (ROC) is 5.00, creating a Buy signal.

FAQ

Is VP2 a Buy, Hold, or Sell?
Based on VP2’s technical indicators, VP2 is a Sell.
    What is VP2’s RSI (14)?
    VP2’s RSI (14) is 47.16, which suggests VP2 is a Neutral.
      What is VP2’s MACD?
      VP2’s MACD is >-0.01, which suggests VP2 is a Buy.
        What is VP2’s 5-day moving average?
        VP2’s 5-day moving average is 0.05, which suggests VP2 is a Sell.
          What is VP2’s 20-day moving average?
          VP2 20-day moving average is 0.05, which suggests VP2 is a Sell.
            What is VP2’s 50-day moving average?
            VP2’s 50-day moving average is 0.05, which suggests VP2 is a Sell.
              What is VP2’s 200-day moving average?
              VP2’s 200-day moving average is 0.09, which suggests VP2 is a Sell.
                What is VP2’s Williams % R (14)?
                VP2’s Williams % R (14) is -87.50, which suggests VP2 is a Buy.
                  What is VP2’s CCI (14)?
                  VP2’s CCI (14) is -76.92, which suggests VP2 is a Neutral.
                    What is the share price of Valeo Pharma?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis